Kana Enomoto is a Senior Expert at McKinsey & Company, where she co-leads the McKinsey Health Institute. She has more than 20 years of experience as a federal executive in mental health and substance-use policy, data, programs, and practice improvement. Kana is an adaptive leader with a strong record of achieving public-policy goals, delivering programmatic impact, and inspiring organizational and social change.
Prior to joining McKinsey, Kana was a senior advisor to the Surgeon General of the United States. In this capacity, she provided strategic guidance to the Surgeon General's efforts to combat the opioid epidemic. Previously, she was acting administrator for the Substance Abuse and Mental Health Services Administration. Appointed in 2015 by former Secretary of Health and Human Services Sylvia Burwell, she provided executive direction and policy leadership for an agency with more than 600 employees and a fiscal year budget of over $4 billion.